Evrofarma Statistics

Total Valuation

Evrofarma has a market cap or net worth of EUR 49.36 million. The enterprise value is 59.86 million.

Market Cap	49.36M
Enterprise Value	59.86M

Important Dates

The last earnings date was Friday, April 17, 2026.

Earnings Date	Apr 17, 2026
Ex-Dividend Date	Aug 19, 2026

Share Statistics

Evrofarma has 13.67 million shares outstanding. The number of shares has decreased by -0.04% in one year.

Current Share Class	13.67M
Shares Outstanding	13.67M
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	72.74%
Owned by Institutions (%)	n/a
Float	3.73M

Valuation Ratios

The trailing PE ratio is 14.00.

PE Ratio	14.00
Forward PE	n/a
PS Ratio	1.00
PB Ratio	2.39
P/TBV Ratio	2.43
P/FCF Ratio	n/a
P/OCF Ratio	13.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.26, with an EV/FCF ratio of -117.60.

EV / Earnings	16.98
EV / Sales	1.21
EV / EBITDA	8.26
EV / EBIT	11.46
EV / FCF	-117.60

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.83.

Current Ratio	2.23
Quick Ratio	1.57
Debt / Equity	0.83
Debt / EBITDA	2.35
Debt / FCF	-33.52
Interest Coverage	7.49

Financial Efficiency

Return on equity (ROE) is 18.33% and return on invested capital (ROIC) is 13.06%.

Return on Equity (ROE)	18.33%
Return on Assets (ROA)	6.24%
Return on Invested Capital (ROIC)	13.06%
Return on Capital Employed (ROCE)	11.44%
Weighted Average Cost of Capital (WACC)	7.12%
Revenue Per Employee	297,843
Profits Per Employee	21,241
Employee Count	210
Asset Turnover	0.95
Inventory Turnover	5.39

Taxes

In the past 12 months, Evrofarma has paid 1.00 million in taxes.

Income Tax	1.00M
Effective Tax Rate	22.09%

Stock Price Statistics

The stock price has increased by +90.00% in the last 52 weeks. The beta is 0.77, so Evrofarma's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+90.00%
50-Day Moving Average	3.60
200-Day Moving Average	3.11
Relative Strength Index (RSI)	52.04
Average Volume (20 Days)	2,821

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evrofarma had revenue of EUR 49.44 million and earned 3.53 million in profits. Earnings per share was 0.26.

Revenue	49.44M
Gross Profit	11.25M
Operating Income	5.22M
Pretax Income	4.53M
Net Income	3.53M
EBITDA	7.17M
EBIT	5.22M
Earnings Per Share (EPS)	0.26

Full Income Statement

Balance Sheet

The company has 6.56 million in cash and 17.06 million in debt, giving a net cash position of -10.50 million or -0.77 per share.

Cash & Cash Equivalents	6.56M
Total Debt	17.06M
Net Cash	-10.50M
Net Cash Per Share	-0.77
Equity (Book Value)	20.66M
Book Value Per Share	1.51
Working Capital	13.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.59 million and capital expenditures -4.10 million, giving a free cash flow of -509,000.

Operating Cash Flow	3.59M
Capital Expenditures	-4.10M
Depreciation & Amortization	1.95M
Net Borrowing	100,000
Free Cash Flow	-509,000
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 22.76%, with operating and profit margins of 10.56% and 7.13%.

Gross Margin	22.76%
Operating Margin	10.56%
Pretax Margin	9.15%
Profit Margin	7.13%
EBITDA Margin	14.51%
EBIT Margin	10.56%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 1.36%.

Dividend Per Share	0.05
Dividend Yield	1.36%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	n/a
Payout Ratio	19.29%
Buyback Yield	0.04%
Shareholder Yield	1.40%
Earnings Yield	7.14%
FCF Yield	-1.03%

Dividend Details

Stock Splits

The last stock split was on July 26, 2001. It was a forward split with a ratio of 2.

Last Split Date	Jul 26, 2001
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5